The ISSCR has hired a director for its policy office. The individual is responsible for directing, planning and executing the society’s policy initiatives to impact standards, policy and regulation pertaining to stem cell research at the state and federal levels as well as internationally.

ISSCR member Lorenz Studer was selected as a recipient of a 2015 MacArthur Genius Award

Comments are now being accepted on the draft of the ISSCR's "Guidelines for Stem Cell Research and Clinical Translation." We encourage you to consider and provide feedback on this important document.

The ISSCR announces Sean J. Morrison, Children’s Research Institute at UT Southwestern Medical Center, as incoming president of the ISSCR board of directors, immediately following the ISSCR’s annual meeting, June 24-27, 2015.

As Director of Commercialization and Licensing at Toronto’s Center for Commercialization of Regenerative Medicine (CCRM), Dr. Moody knows first hand the benefits of translational research – and a good sense of humor. She quips, “Most of my close colleagues know that I am a breast cancer survivor… Yes, I am very young for that kind of thing, thank you for noticing.” Read more about her focus on the business side of regenerative medicine and what a train, angry birds and ninja turtles have in common in this month’s Member Spotlight.

The ISSCR announces two media panels - "Promise, Progress & Hype" (25 June), exploring the complex issues surrounding the marketing and sale of experimental stem cell treatments and "Highlights from the Scientific Program" (26 June), talks from international panelists who are harnessing stem cells to treat disease and who will present their research in the areas of macular degeneration, heart disease and diabetes.

The International Society for Stem Cell Research (ISSCR) is now accepting media registration for its 13th annual meeting, the world’s largest international, interdisciplinary forum dedicated to stem cell science.

Longtime ISSCR member Ola Hermanson of Sweden’s Karolinska Institutet uses an integrative approach to study neural development and cellular events that he hopes (only half-jokingly) will eventually lead to a clone of his own brain. "Such a 'silly' goal, however, results in a lot of serious questions..." says Hermanson. Find out more about those questions and how this “old wannabe-hipster” musician became a stem cell scientist at all in this month’s Member Spotlight.

In response to an article published by Chinese scientists describing research that used gene editing technologies in human embryos, the International Society for Stem Cell Research (ISSCR) has again called for a moratorium on attempts at human clinical germline genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications.

The ISSCR launched an expanded “Closer Look at Stem Cells” website (www.closerlookatstemcells.org), an online resource to help patients and their families make informed decisions about stem cell treatments, clinics and their health.

The ISSCR has launched an expanded “Closer Look at Stem Cells” website (www.closerlookatstemcells.org), an online resource to help patients and their families make informed decisions about stem cell treatments, clinics and their health.

Dr. Brickman’s group at the Danish Stem Cell Centre (DanStem) seeks to understand the transcriptional basis for lineage choice in embryos and embryonic stem cells. Learn more about their work and what musical avocation he naïvely tried to continue while completing his PhD in this month’s Member Spotlight.

The ISSCR Congratulates Past President Dr. Janet Rossant on her Receipt of the Canada Gairdner Wightman Award

The International Society for Stem Cell Research calls for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.

As a professor at Stockholm, Sweden’s Karolinska Institutet, the contemplative Dr. Hovatta and her team are working on xeno-free, feeder cell-free differentiation of retinal pigment epithelial cells from hESC. Discover what surprising and sometimes extreme activities help bring inspiration and clarity to Dr. Hovatta's work in this month’s Member Spotlight.